Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (33303)
All Articles published online
|
Publishing Process of This Article
|
Jan 30, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Pharmacology
ISSN
2220-3192
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2019 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | 124 | 39.7% | |
| 2 | United States | 53 | 17% |
| 3 | Germany | 26 | 8.3% |
| 4 | India | 11 | 3.5% |
| 5 | United Kingdom | 10 | 3.2% |
| 6 | Thailand | 9 | 2.9% |
| 7 | Indonesia | 8 | 2.6% |
| 8 | Russia | 7 | 2.2% |
| 9 | Finland | 5 | 1.6% |
| 10 | Australia | 5 | 1.6% |
| 11 | Canada | 4 | 1.3% |
| 12 | Ukraine | 4 | 1.3% |
| 13 | Turkey | 3 | 1% |
| 14 | Singapore | 3 | 1% |
| 15 | Sweden | 3 | 1% |
| 16 | Korea, Republic of | 3 | 1% |
| 17 | New Zealand | 2 | 0.6% |
| 18 | Switzerland | 2 | 0.6% |
| 19 | Bulgaria | 2 | 0.6% |
| 20 | Hungary | 2 | 0.6% |
| 21 | France | 2 | 0.6% |
| 22 | Iran, Islamic Republic of | 2 | 0.6% |
| 23 | Viet Nam | 2 | 0.6% |
| 24 | Italy | 1 | 0.3% |
| 25 | Japan | 1 | 0.3% |
| 26 | Greece | 1 | 0.3% |
| 27 | China | 1 | 0.3% |
| 28 | Colombia | 1 | 0.3% |
| 29 | Estonia | 1 | 0.3% |
| 30 | Europe | 1 | 0.3% |
| 31 | Bangladesh | 1 | 0.3% |
| 32 | Brazil | 1 | 0.3% |
| 33 | Taiwan | 1 | 0.3% |
| 34 | South Africa | 1 | 0.3% |
| 35 | Spain | 1 | 0.3% |
| 36 | Norway | 1 | 0.3% |
| 37 | Philippines | 1 | 0.3% |
| 38 | Poland | 1 | 0.3% |
| 39 | Portugal | 1 | 0.3% |
| 40 | Romania | 1 | 0.3% |
| 41 | Latvia | 1 | 0.3% |
| 42 | Malaysia | 1 | 0.3% |
| 43 | Mexico | 1 | 0.3% |